Sotera Health Co (SHC)
About Sotera Health Co
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.2B
- Net income
- $77.9M
- Total assets
- $3.3B
- Market cap
- $4.5B
- Gross margin
- 55.5%
- Operating margin
- 12.7%
- Net margin
- 6.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.2B
- Cost of revenue
- $518.1M
- Gross profit
- $645.5M
- Operating expenses
- $498.0M
- Operating income
- $147.5M
- Income tax
- $69.6M
- Net income
- $77.9M
- EPS (basic)
- $0.27
- EPS (diluted)
- $0.27
Balance sheet
- Total assets
- $3.3B
- Current assets
- $613.4M
- Total liabilities
- $2.7B
- Current liabilities
- $249.6M
- Shareholders’ equity
- $606.0M
Cash flow
- Operating cash flow
- $287.2M
- Investing cash flow
- -$135.1M
- Financing cash flow
- -$100.5M
- Net cash flow
- $67.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.5B
- P/E ratio
- 64.3
- EPS (diluted)
- $0.27
- Shares outstanding
- 256.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 20, 2020
Sotera Health Co (SHC) Stock Price
- Profitable — net income of $77.9M in FY2025.
- Revenue grew 25% from FY2021 to FY2025.
- Gross margin of 55.5%, net margin 6.7%.
- Trading 10% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 64.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Sotera Health Co.
Write a review
News about Sotera Health Co
News & sentiment via Polygon.io
Sotera Health Co: frequently asked questions
Is Sotera Health Co an American company?
Sotera Health Co is a US-based company headquartered in Broadview Heights, Ohio, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Sotera Health Co headquartered?
Sotera Health Co is headquartered in Broadview Heights, Ohio, United States.
Is Sotera Health Co publicly traded?
Yes — Sotera Health Co is a publicly traded company. Its stock trades under the ticker symbol SHC on the NASDAQ.
What does Sotera Health Co do?
Sotera Health Co is an American Medical Devices company in the Health & Beauty sector.
